Skip to main content
Premium Trial:

Request an Annual Quote

Autogenomics Receives ISO Certification

Premium

By Justin Petrone

AutoGenomics said last week that it has received ISO 13485 certification — an International Organization for Standardization standard that covers the requirements for the design and manufacture of medical devices.

TÜV SÜD America, a global inspection firm, was the certification body.

CEO Fareed Kureshy called the certification a "significant milestone" for Autogenomics, which sells a microarray-based molecular diagnostics platform called Infiniti, and has had a number of tests cleared for clinical use in the US and Europe.

In recent years, the Carlsbad, Calif.-based company has had several tests cleared by the US Food and Drug Administration as in vitro diagnostics, including factor II, factor V Leiden, factor II-V Leiden assays for the diagnosis of suspected thrombophilia, as well as an assay for the detection of sensitivity to the anticoagulant drug warfarin..

The company also has 13 CE Marked panels for sale in 15 different countries. According to Kureshy, the recent ISO certification will aid Autogenomics as it "expands its increasing role in the international market."

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.